456 related articles for article (PubMed ID: 33257644)
1. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
[TBL] [Abstract][Full Text] [Related]
2. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
medRxiv; 2021 Dec; ():. PubMed ID: 34909794
[TBL] [Abstract][Full Text] [Related]
5. Evidence of SARS-CoV-2 symptomatic reinfection in four healthcare professionals from the same hospital despite the presence of antibodies.
Gargouri S; Souissi A; Abid N; Chtourou A; Feki-Berrajah L; Karray R; Kossentini H; Ben Ayed I; Abdelmoula F; Chakroun O; Nasri A; Hammami A; Rekik N; Masmoudi S; Karray-Hakim H; Rebai A
Int J Infect Dis; 2022 Apr; 117():146-154. PubMed ID: 35017107
[TBL] [Abstract][Full Text] [Related]
6. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
[TBL] [Abstract][Full Text] [Related]
7. A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.
Beppu H; Ogawa T; Ishikane M; Kawanishi T; Fukuda T; Sato L; Matsunaga A; Maeda K; Katagiri D; Ishizaka Y; Mitsuya H; Ohmagari N; Yasui F; Kohara M; Kikuchi K; Wakai S
CEN Case Rep; 2022 Nov; 11(4):422-427. PubMed ID: 35266095
[TBL] [Abstract][Full Text] [Related]
8. [Longitudinal Monitoring of Seroconversion Status in SARS-CoV-2 RT-PCR Positive Healthcare Workers].
Ersoy L; Tezcan Ülger S; Gülbudak H; Yaşar N; Yapıcı G; Aslan G
Mikrobiyol Bul; 2022 Jan; 56(1):114-123. PubMed ID: 35088965
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection of a Healthcare Worker in a Belgian Nosocomial Outbreak Despite Primary Neutralizing Antibody Response.
Selhorst P; van Ierssel SH; Michiels J; Mariën J; Bartholomeeusen K; Dirinck E; Vandamme S; Jansens H; Ariën KK
Clin Infect Dis; 2021 Nov; 73(9):e2985-e2991. PubMed ID: 33315049
[TBL] [Abstract][Full Text] [Related]
10. A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?
Tuan J; Spichler-Moffarah A; Ogbuagu O
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33542020
[TBL] [Abstract][Full Text] [Related]
11. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
12. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Antibody Levels and SARS-Cov-2 Reinfection.
Islamoglu MS; Cengiz M; Uysal BB; Ikitimur H; Ozdemir Z; Karamehmetoglu A; Akbulut AE; Bakdur AN; Ozdemir A; Kayıkcıoglu H; Ozdemir H; Uces R; Ersoy S; Yavuzer S
Ann Clin Lab Sci; 2021 Nov; 51(6):750-755. PubMed ID: 34921027
[TBL] [Abstract][Full Text] [Related]
14. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
[TBL] [Abstract][Full Text] [Related]
16. A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia.
Scutari R; Fox V; De Ioris MA; Fini V; Granaglia A; Costabile V; Colagrossi L; Russo C; Mastronuzzi A; Locatelli F; Perno CF; Alteri C
BMC Infect Dis; 2023 Mar; 23(1):133. PubMed ID: 36882724
[TBL] [Abstract][Full Text] [Related]
17. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
[TBL] [Abstract][Full Text] [Related]
18. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
19. Natural immune response and protection from SARS-CoV-2 reinfection.
Margiotti K; Fabiani M; Mesoraca A; Giorlandino C
Acta Virol; 2021; 65(4):333-338. PubMed ID: 34796710
[TBL] [Abstract][Full Text] [Related]
20. Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.
Cohen DE; Sibbel S; Marlowe G; Bludorn K; Miller D; Kelley T; Connaire J; Young A; Tentori F; Brunelli SM
J Am Soc Nephrol; 2021 Aug; 32(8):1880-1886. PubMed ID: 34215666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
